ClinicalTrials.Veeva

Menu

Lumbar Transforaminal Epidural Dexamethasone

A

Ahadian, Farshad M., M.D.

Status

Completed

Conditions

Radicular; Neuropathic, Lumbar, Lumbosacral

Treatments

Procedure: Lumbar Transforaminal Epidural Steroid Injection

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT01303354
UCSD IRB 080582

Details and patient eligibility

About

The aim of this study is to assess the effectiveness and safety of dexamethasone for transforaminal epidural steroid injection. A secondary aim of this study is to obtain data on the lowest most effective dose of dexamethasone for this treatment and the effective duration of effect.

Full description

Transforaminal epidural steroid injections (TFESI) have been demonstrated to be an effective treatment for radicular pain. Over the last decade, rare but serious complications have been reported following transforaminal epidural steroid injections (TFESI). Recent research indicates that certain types of corticosteroids containing microscopic particles may be responsible for these adverse events. Dexamethasone (DXM) is a non-particulate cortico-steroid that has not been implicated in these adverse events. However, there is inadequate evidence up to date to support the use of Dexamethasone (DXM) for transforaminal epidural steroid injections (TFESI). This study aims to bridge that gap.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adults age 18 years and older, unilateral lumbar radicular pain, baseline distal radicular lower extremity pain VAS score ≥ 5/10, and prior favorable response to TFESI

Exclusion criteria

  • pregnancy, infection, coagulopathy, uncontrolled diabetes mellitus, history of allergy to iodinated contrast medium and interventional therapies for pain within 90 days prior to study enrollment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 3 patient groups

DXM 4 mg
Experimental group
Description:
Dexamethasone 4 mg
Treatment:
Procedure: Lumbar Transforaminal Epidural Steroid Injection
DXM 8 mg
Experimental group
Description:
Dexamethasone 8 mg
Treatment:
Procedure: Lumbar Transforaminal Epidural Steroid Injection
DXM 12 mg
Experimental group
Description:
Dexamethasone 12 mg
Treatment:
Procedure: Lumbar Transforaminal Epidural Steroid Injection

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems